4Corey DR. Chemical modification: the key to clinical application of RNA interference? J Clin Invest, 2007, 117:3615-3622.
5de Fougerolles AR. Delivery vehicles for small interfering RNA in vivo. Hum Gene Ther, 2008, 19: 125-132.
6Akazawa Y, Gores GJ. Death receptor-mediated liver injury. Semin Liver Dis, 2007, 27: 327-338.
7Song E, Lee SK, Wang J, et al. RNA interference targeting Fas protects mice from fulminant hepatitis. Nat Med, 2003, 9: 347-351.
8Zender L, Hutker S, Liedtke C, et al. Caspase 8 small interfering RNA prevents acute liver failure in mice. Proc Natl Acad Sci U S A, 2003, 100: 7797-7802.
9Mizuguchi Y, Yokomuro S, Mishima T, et al. Short hairpin RNA modulates transforming growth factor beta signaling in life-threatening liver failure in mice. Gastroenterology, 2005, 129: 1654-1662.
10Arai M, Yokosuka O, Kanda T, et al. Serum osteopontin levels in patients with acute liver dysfunction, Scand J Gastroenterol, 2006, 41: 102-110.
